Azelis distributes Gattefossé’s complete portfolio of lipid-based excipients for the Pharmaceuticals & Healthcare segment in Malaysia
Azelis, a leading innovation service provider in the specialty chemicals and food ingredients industry, is pleased to announce a new distribution agreement with Gattefossé, a leading developer and manufacturer of pharmaceutical excipients and cosmetic ingredients of natural origin for beauty and health industries worldwide. Effective immediately, Azelis distributes Gattefossé’s complete portfolio of lipid-based excipients for the Pharmaceuticals & Healthcare segment in Malaysia.
Leveraging a longstanding commercial relationship between Azelis and Gattefossé for Personal Care in Malaysia and China in Asia Pacific, and multiple markets in the EMEA region, the partnership extension to Pharmaceuticals & Healthcare is a testament to a successful ongoing collaboration.
Gattefossé's comprehensive range of ingredients enhances bioavailability, taste-masking, and flowability to improve the stability, delivery, and effectiveness of drug formulations. These factors offer versatility in healthcare applications through oral, topical, and suppository formats.
Angelito Delos Reyes, General Manager of Gattefossé Asia Pacific, says: “We are pleased to expand our collaboration with Azelis into Pharmaceuticals & Healthcare. Azelis’ deep market knowledge, customer focus, regulatory and technical expertise complement our offerings. We look forward to jointly supporting customers with effective solutions to address the evolving needs of the healthcare industry.”
Sylvia Wee, Managing Director of Azelis Malaysia, adds: “We are delighted to introduce Gattefossé’s pharmaceutical solutions to our product offering in Malaysia, building on our collaboration in Personal Care. The partnership strengthens Azelis’ position in the growing pharmaceutical industry in Malaysia through a broader product portfolio, enabling us to deliver innovative solutions to our customers.”
Subscribe To Our Newsletter & Stay Updated